Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 130

Results For "data"

1908 News Found

Excelra Partners with HotSpot Therapeutics to enhance allosteric drug discovery efforts
Biotech | May 26, 2022

Excelra Partners with HotSpot Therapeutics to enhance allosteric drug discovery efforts

The partnership aims to enhance HotSpot's drug discovery and development efforts by incorporating GOSTAR's high-quality, annotated datasets into HotSpot's machine learning (ML) and artificial intelligence (AI) models


Daman collaborates with Janssen to develop digital health tool
Biotech | May 26, 2022

Daman collaborates with Janssen to develop digital health tool

The aim is to provide further insights into patients' lives in the effort to deliver better outcomes for people with psoriatic arthritis (PsA)


Cipla scored highest among pharma companies in CRISIL’s Sustainability Rating 2022
Sustainability | May 25, 2022

Cipla scored highest among pharma companies in CRISIL’s Sustainability Rating 2022

By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry


Sputnik V demonstrates strong protection against Omicron variant
Biotech | May 25, 2022

Sputnik V demonstrates strong protection against Omicron variant

The study was conducted in equal laboratory conditions in the Spallanzani Institute in Italy on comparable sera samples from individuals vaccinated with Sputnik V and Pfizer with a similar level of IgG antibodies and virus-neutralizing activity (VNA) against Wuhan variant.


Cadila Pharma launches Belmore to treat uncontrolled LDL-cholesterol
Drug Approval | May 24, 2022

Cadila Pharma launches Belmore to treat uncontrolled LDL-cholesterol

Belmore, the brand name of Bempedoic acid, is a novel drug for the treatment of high LDL-cholesterol.


NHA announces revamped ABHA mobile application
News | May 24, 2022

NHA announces revamped ABHA mobile application

The revamped Ayushman Bharat Health Account (ABHA) mobile application offers added functionalities and a new User Interface (UI)


CHMP recommends European Commission approval of Rinvoq
Drug Approval | May 23, 2022

CHMP recommends European Commission approval of Rinvoq

Ulcerative colitis is a chronic, immune-mediated inflammatory bowel disease that can lead to substantial burden and often disability among patients


Dapagliflozin met primary endpoint in DELIVER Phase III trial
Biotech | May 23, 2022

Dapagliflozin met primary endpoint in DELIVER Phase III trial

Results from the DELIVER and DAPA-HF Phase III trials demonstrate Dapagliflozin’ efficacy in heart failure regardless of ejection fraction


New study finds that Masimo PVi may be useful in helping ER doctors determine the severity of asthma attacks
Biotech | May 23, 2022

New study finds that Masimo PVi may be useful in helping ER doctors determine the severity of asthma attacks

Acute asthma attack is a common cause of admission to emergency departments (EDs) among children, and triage by severity is important for determining appropriate clinical treatment


Novavax files for expanded conditional marketing authorisation for Nuvaxovid as a booster in Europe
News | May 21, 2022

Novavax files for expanded conditional marketing authorisation for Nuvaxovid as a booster in Europe

The European Commission granted CMA in December 2021 for use of Nuvaxovid in individuals aged 18 and over, and Novavax filed for expanded CMA for use in adolescents aged 12 through 17 in March 2022